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To determine previous exposure and incidence of 
rickettsial infections in western Kenya during 2007–2010, 
we conducted hospital-based surveillance. Antibodies 
against rickettsiae were detected in 57.4% of previously 
collected serum samples. In a 2008–2010 prospective 
study,  Rickettsia felis DNA was 2.2× more likely to be 
detected in febrile than in afebrile persons. 
R
ickettsioses are a major human health problem in 
many parts of the world, including sub-Saharan 
Africa (1,2). Awareness of rickettsiae as causes of public 
health problems has been increasing; several novel or 
emerging diseases caused by these pathogens have been 
recognized. In Kenya, recent reports have documented 
human infections with Rickettsia conorii (3,4) and R. felis 
(5) and tick infection with R. africae (6). Our objectives 
were to assess previous human exposure to rickettsiae and 
to determine the incidence of rickettsial infections among 
febrile and afebrile persons in western Kenya.
The Study
The study was conducted among patients visiting 
the Lwak Mission Hospital, a rural health care facility in 
western Kenya in the Asembo area, Rarieda District, in 
western Kenya (Figure 1). Lwak Mission Hospital serves 
as the ﬁ  eld clinic for population-based infectious disease 
surveillance conducted by the Kenya Medical Research 
Institute and the US Centers for Disease Control and 
Prevention as described (7). The study was conducted with 
ethical approval from these institutions (protocol nos. 932 
and 4566, respectively). To assess previous exposure to 
rickettsiae, we examined a randomly selected subset of 357 
serum specimens collected January 2007 through October 
2008 from patients participating in population-based 
infectious disease surveillance. Samples were screened 
at a dilution of 1:128 for IgG against spotted fever group 
(SFG) and typhus group (TG) rickettsiae by using an 
indirect ﬂ  uorescence antibody assay (Fuller Laboratories, 
Fullerton, CA, USA).
Blood specimens were collected from the ﬁ  rst  2 
outpatients ≈5 years of age and the ﬁ  rst 2 outpatients <5 
years of age seen each day for acute febrile illness (recorded 
axillary temperature >38.0°C without an obvious cause, 
deﬁ   ned as cough, difﬁ   culty breathing, chest pain, signs 
of meningitis, or bloody diarrhea) from November 2008 
through February 2010. A positive malaria smear was 
not an exclusion criterion. During the same period, blood 
specimens were also collected from controls: a group of 
outpatients who did not have febrile, respiratory, or diarrheal 
illness during the preceding 2 weeks and asymptomatic 
persons who accompanied patients to the clinic.
To detect rickettsial DNA, we performed 3 quantitative 
PCRs: a genus-speciﬁ  c assay selective for a 74-bp segment 
of the citrate synthase (gltA) gene, a group-speciﬁ  c assay 
that detects a 128-bp segment of the outer membrane protein 
(ompB) gene for tick-borne rickettsiae, and a species-
speciﬁ  c assay that detects a 129-bp segment of the ompB 
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Figure 1. Locations of villages (brown shading in inset map) in 
Asembo area of western Kenya where the study was conducted, 
January 2007 through October 2008.  Used with permission of 
Kenya Medical Research Institute/Centers for Disease Control and 
Prevention Research and Public Health Collaboration.Rickettsia felis Infection, Western Kenya
gene for R. felis (5,8). To identify which Rickettsia sp. was 
present in the positive specimens, we PCR ampliﬁ  ed and 
sequenced segments of 4 rickettsial genes—17-kDa, ompB, 
and 2 R. felis plasmid genes (pRF and pRFδ)—by using 
primers and procedures as described (5).
Overall, 205 (57.4%) of 357 specimens had antibodies 
against rickettsiae. Of 357 serum specimens tested, 
200 (56.0%, 95% exact binomial CI 50.7%–61.2%) 
had detectable IgG against SFG antigen preparation. 
Antibodies against TG antigen preparation were detected 
in 52 (14.5%, 95% CI 11.0%–18.6%) of 357 specimens 
tested; 47 (90.4%) of these specimens that reacted to TG 
antigens were also positive for SFG antigens, and 5 (1.4%) 
of the 357 specimens were positive for TG antigens alone. 
Presence of antibodies against SFG or TG antigens was not 
associated with patient sex (p>0.05). In addition, patient 
age was not signiﬁ  cantly associated with TG seropositivity 
(χ2 for linear trend 3.41, df 1, p = 0.065). However, an 
incremental linear association was demonstrated between 
age and IgG seropositivity to SFG (χ2 for linear trend 45.46, 
df 1, p<0.001) (Figure 2).
A total of 699 febrile patients who sought care at Lwak 
Mission Hospital from November 2008 through February 
2010 and 236 afebrile persons enrolled during this same 
period were tested for rickettsiae (Table 1). Overall, 50 
(7.2%, 95% CI 5.4%–9.3%) of the febrile patients and 8 
(3.4%, 95% CI 1.5%–6.6%) of the afebrile persons had 
positive rickettsiae results according to the genus-speciﬁ  c 
gltA assay. Univariate logistic regression indicated that 
febrile patients were more likely than afebrile persons 
to have positive PCR results (odds ratio 2.20, 95% CI 
1.03–4.70, p = 0.04). According to the ompB assay, all 
specimens tested were negative for tick-borne rickettsiae. 
BLAST searches (www.ncbi.nlm.nih.gov/blast/Blast.cgi) 
for homologous sequences determined that the segments 
ampliﬁ  ed from the 3 genes had 100% nt homology with R. 
felis URRXWCal2 (Table 2).
In addition to fever, the most common clinical 
manifestations among patients with positive PCR results 
for rickettttsiae were headaches (100%), chills (93.8%), 
muscle aches (68.8%), and joint pains (68.8%). Rash was 
reported for 4.4% of rickettsiae-positive patients. Among 
febrile patients, no statistically signiﬁ  cant  associations 
were found between speciﬁ   c signs or symptoms and 
positive PCR results for rickettsiae (p>0.05). Samples from 
all febrile patients were Giemsa stained and examined; 
malaria parasites were detected in 79.2% and 73.4% of 
samples from patients who had PCR-positive and PCR-
negative results for rickettsiae, respectively.
Conclusions
The 2007–2008 serosurvey found prevalence of IgG 
against rickettsiae to be high. Other countries in Africa have 
reported similar (28%–58%) seroprevalence (9,10). The 
ﬁ  nding that prevalence of IgG to SFG rickettsiae increased 
with age can, in part, be explained by cumulative exposure 
to the pathogen and lifelong persistence of IgG. The high 
number of patients seropositive for SFG and TG rickettsiae 
may be attributed to cross-reactivity between SFG and TG 
rickettsial antigens (11), although results from studies in 
animal models show that cross-reactivity between SFG 
and TG rickettsiae is not consistent (12). Znazen et al. (13) 
speculate that antibodies against R. felis may be the major 
cause of cross-reactions to TG-rickettsiae–speciﬁ  c  and 
SFG-rickettsiae–speciﬁ  c antigens.
The identiﬁ  cation of R. felis DNA sequences in febrile 
patients conﬁ   rms the previous ﬁ   nding of this pathogen 
among febrile patients in Kenya (5). Our ﬁ  ndings  are 
also similar to those from northern Tanzania, where acute 
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Figure 2. Age-stratiﬁ  ed seroprevalence of IgG to rickettsiae among 
patients participating in population-based infectious disease 
surveillance, January 2007 through October 2008. Vertical lines 
indicate 95% binomial CIs.
Table 1. Demographic characteristics of participants in hospital-
based survey, western Kenya, 2008–2010 
Characteristic
No. (%) febrile, 
n = 699 
No. (%) afebrile, 
n = 236  p value* 
Age group, y       <0.001 
  0–1   61 (8.7)  15 (7.0) 
  2–5   345 (49.4)  30 (14.1) 
  6–17   214 (30.6)  63 (29.6) 
  18–44   61 (8.7)  72 (33.8) 
 >45    18 (2.6)  33 (15.5) 
 Missing    0  23 
Sex       <0.001 
  M   352 (50.6)  73 (30.4) 
  F   344 (49.4)  163 (69.1) 
 Missing    3  0 
*By Ȥ
2 test. rickettsiosis was serologically conﬁ  rmed for 8% of febrile 
hospital inpatients (14), and from rural Senegal, where 6% 
of febrile patients without malaria had positive R. felis test 
results (15). Our ﬁ  ndings suggest that rickettsial infections 
should be considered in the differential diagnosis of febrile 
cases in western Kenya and that diagnostic capacity should 
be established. Clinicians in malaria-endemic areas should 
consider rickettsial co-infections in diagnostic protocols and 
treatment of patients with malaria and other febrile illnesses.
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